Veterinary Medicines

LABIDROSOL B SOLUCION INYECTABLE

Authorised
  • Pyridoxine hydrochloride
  • Dexpanthenol
  • Cyanocobalamin
  • RIBOFLAVIN SODIUM PHOSPHATE
  • Nicotinamide
  • Thiamine hydrochloride
Download as PDF

Product identification

Medicine name:
LABIDROSOL B SOLUCION INYECTABLE
Active substance:
  • Pyridoxine hydrochloride
  • Dexpanthenol
  • Cyanocobalamin
  • RIBOFLAVIN SODIUM PHOSPHATE
  • Nicotinamide
  • Thiamine hydrochloride
Target species:
  • Cattle
  • Sheep
  • Goat
  • Horse
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Pyridoxine hydrochloride
    5.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Dexpanthenol
    20.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Cyanocobalamin
    0.10
    milligram(s)
    /
    1.00
    millilitre(s)
  • RIBOFLAVIN SODIUM PHOSPHATE
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Nicotinamide
    40.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Thiamine hydrochloride
    12.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        0
        day
      • Milk
        0
        day
    • Pig
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11EA
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Available in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Labiana Life Sciences S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • Spanish Agency For Medicines And Health Products
Authorisation number:
  • 3717 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."